BIOMAT Database Logo BIOMAT Database Logo

Tenofovir-related nephrotoxicity: an ongoing clinical challenge. 2013

Michelle M Foisy, and Christine Hughes, and Cara Hills-Nieminen, and Ameeta E Singh, and A Mark Joffe

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068698 Tenofovir An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone. (R)-9-(2-phosphonylmethoxypropyl)adenine,9-(2-Phosphonomethoxypropyl)adenine,9-(2-Phosphonylmethoxypropyl)adenine,9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer,9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098,9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer,9-PMPA (tenofovir),Tenofovir Disoproxil,Tenofovir Disoproxil Fumarate,Viread,Disoproxil Fumarate, Tenofovir,Disoproxil, Tenofovir,Fumarate, Tenofovir Disoproxil
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Michelle M Foisy, and Christine Hughes, and Cara Hills-Nieminen, and Ameeta E Singh, and A Mark Joffe
Immune checkpoint inhibitor induced nephrotoxicity: An ongoing challenge.
January 2022, Frontiers in medicine,
Michelle M Foisy, and Christine Hughes, and Cara Hills-Nieminen, and Ameeta E Singh, and A Mark Joffe
Age-related macular disease: an ongoing challenge.
December 2003, Clinical & experimental ophthalmology,
Michelle M Foisy, and Christine Hughes, and Cara Hills-Nieminen, and Ameeta E Singh, and A Mark Joffe
Tenofovir-related nephrotoxicity in HIV-infected patients.
April 2004, AIDS (London, England),
Michelle M Foisy, and Christine Hughes, and Cara Hills-Nieminen, and Ameeta E Singh, and A Mark Joffe
[Tenofovir nephrotoxicity].
June 2016, Nephrologie & therapeutique,
Michelle M Foisy, and Christine Hughes, and Cara Hills-Nieminen, and Ameeta E Singh, and A Mark Joffe
[Delayed graft function : an ongoing clinical challenge].
February 2023, Revue medicale de Liege,
Michelle M Foisy, and Christine Hughes, and Cara Hills-Nieminen, and Ameeta E Singh, and A Mark Joffe
Congenital diaphragmatic hernia: an ongoing clinical challenge.
June 2008, Current opinion in pediatrics,
Michelle M Foisy, and Christine Hughes, and Cara Hills-Nieminen, and Ameeta E Singh, and A Mark Joffe
Heat related illnesses. Review of an ongoing challenge.
December 2019, Saudi medical journal,
Michelle M Foisy, and Christine Hughes, and Cara Hills-Nieminen, and Ameeta E Singh, and A Mark Joffe
An ongoing challenge.
October 1992, Iowa medicine : journal of the Iowa Medical Society,
Michelle M Foisy, and Christine Hughes, and Cara Hills-Nieminen, and Ameeta E Singh, and A Mark Joffe
Editorial comment: tenofovir-related nephrotoxicity--who's at risk?
February 2007, The AIDS reader,
Michelle M Foisy, and Christine Hughes, and Cara Hills-Nieminen, and Ameeta E Singh, and A Mark Joffe
Tuberculosis: an ongoing challenge.
January 2005, Cadernos de saude publica,
Copied contents to your clipboard!